← All cheat sheets

Missed an Ozempic Dose? The Five-Day Window Explained

Last verified May 2026 · 4 min read · DailyMed-sourced

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

Ozempic is semaglutide, injected weekly. If you forget one, the label answers the question with a single number: five days from the day it was due.

The decision

How long it has beenWhat to doWhy
Five days or less Take it now, then go back to your normal weekly day. Semaglutide hangs around for roughly a week, so a dose given inside five days keeps your levels broadly where they should be.
More than five days Skip it. Your next dose happens on its usual day. Injecting close to the next scheduled shot stacks two doses inside one half-life, and your gut pays for it.

Five, not four. Older patient handouts sometimes quote a four-day window, and some people apply the four-day rule they learned on Zepbound or Mounjaro. Those really are four days — Ozempic really is five. The windows are not interchangeable, and neither are the drugs.

The 48-hour floor

  • Never put two injections within two days of each other, even when catching up. Doses stacked that close sharply raise nausea, vomiting and the dehydration that follows.
  • Changing your weekly day works on the same limit. Sunday to Wednesday is fine — three days. Sunday to Monday is not; wait out the full week instead.
  • The five-day rule does not change with your dose. It reads the same at 0.25 mg as at 2 mg.

When the gap is weeks, not days

Here the label stops helping. It sets no restart algorithm for long interruptions, so what follows is the cautious pattern prescribers tend to use rather than anything the FDA has written down — which is exactly why this belongs in a conversation rather than a lookup.

  • Two to four weeks: many clinicians pick up at the same dose, with some preparation for the nausea — smaller meals, more fluid.
  • Four to eight weeks: commonly a step down, say from 1 mg back to 0.5 mg, held four weeks before climbing again. Tolerance to the gastrointestinal effects fades faster than people expect.
  • Beyond eight weeks: usually a restart from 0.25 mg and back up the standard ladder.

If you take Ozempic for type 2 diabetes this matters more, not less — a restart moves your blood sugar around and any insulin or sulfonylurea you take may need adjusting alongside it.

What to watch for after restarting

  • A gastrointestinal flare from climbing too fast — particularly vomiting or diarrhea that stops you keeping fluids down for a day. Kidney injury from dehydration is on the label.
  • Shaking, sweating, confusion where insulin or a sulfonylurea is also in play. The label flags that combination specifically, and those doses may need to come down during a restart.
  • Severe abdominal pain, especially reaching to the back. Pancreatitis. Hold the next dose and get seen.
  • Right-sided pain under the ribs, fever, yellowing, pale stools. Gallbladder disease is a listed reaction.
  • Hives, a swollen face or throat, trouble breathing. Do not take another dose; get emergency care.
  • Sight altering, if you have type 2 diabetes — blood sugar improving quickly can briefly set retinopathy back.

Storage, since it is the other thing people get wrong

Unused pens belong in the fridge. Once a pen is in use it will keep 56 days at room temperature, up to 86°F. That is a much longer grace period than tirzepatide's pens allow, which is another reason not to reason across drugs. A pen that has frozen goes in the bin regardless.

Outside this page's scope

  • Moving to Wegovy. Different dose range, different ladder. Your Ozempic dose does not transfer across.
  • Time zones. A few hours from a long flight changes nothing. Permanently adopting a new weekly day is the thing that needs 48 hours of clearance.
  • Children, pregnancy, and reduced kidney function, each of which has its own section in the label.

Where to go next

References

  1. 1.U.S. National Library of Medicine — DailyMed. OZEMPIC (semaglutide) injection — Structured Product Label. DailyMed (FDA-approved labeling, SetID adec4fd2-6858-4c99-91d4-531f5f2a2d79). 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  2. 2.Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). N Engl J Med. 2016. PMID: 27633186.

Frequently Asked Questions

Related cheat sheets

This cheat sheet is editorial reference content, not medical advice. Dose adjustments, holds, and discontinuations should be made with your prescriber. Every dose number on this page was verified against the FDA-approved DailyMed Structured Product Label in May 2026.

Browse all cheat sheets, top-N research lists, or long-form research deep-dives.